161 related articles for article (PubMed ID: 34926249)
1. Transcriptomic Profiling Revealed Plexin A2 Downregulation With Migration and Invasion Alteration in Dacarbazine-Treated Primary Melanoma Cells.
Tyumentseva A; Averchuk A; Palkina N; Zinchenko I; Moshev A; Savchenko A; Ruksha T
Front Oncol; 2021; 11():732501. PubMed ID: 34926249
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion alterations in G0-positive melanoma cells.
Esimbekova AR; Palkina NV; Zinchenko IS; Belenyuk VD; Savchenko AA; Sergeeva EY; Ruksha TG
Cancer Med; 2023 Mar; 12(6):7294-7308. PubMed ID: 36533319
[TBL] [Abstract][Full Text] [Related]
3. Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression.
Scott GA; McClelland LA; Fricke AF; Fender A
J Invest Dermatol; 2009 Apr; 129(4):954-63. PubMed ID: 18987670
[TBL] [Abstract][Full Text] [Related]
4. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
[TBL] [Abstract][Full Text] [Related]
5. Plexin B1 inhibits integrin-dependent pp125FAK and Rho activity in melanoma.
McClelland L; Chen Y; Soong J; Kuo I; Scott G
Pigment Cell Melanoma Res; 2011 Feb; 24(1):165-74. PubMed ID: 21029396
[TBL] [Abstract][Full Text] [Related]
6. Parthenolide enhances dacarbazine activity against melanoma cells.
Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
[TBL] [Abstract][Full Text] [Related]
7. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
9. Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.
Stevens L; McClelland L; Fricke A; Williamson M; Kuo I; Scott G
J Invest Dermatol; 2010 Jun; 130(6):1636-45. PubMed ID: 20164843
[TBL] [Abstract][Full Text] [Related]
10. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
Lev DC; Onn A; Melinkova VO; Miller C; Stone V; Ruiz M; McGary EC; Ananthaswamy HN; Price JE; Bar-Eli M
J Clin Oncol; 2004 Jun; 22(11):2092-100. PubMed ID: 15123733
[TBL] [Abstract][Full Text] [Related]
11. The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis.
Lazova R; Gould Rothberg BE; Rimm D; Scott G
Am J Dermatopathol; 2009 Apr; 31(2):177-81. PubMed ID: 19318806
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin-Plexin signaling influences early ventral telencephalic development and thalamocortical axon guidance.
Mitsogiannis MD; Little GE; Mitchell KJ
Neural Dev; 2017 Apr; 12(1):6. PubMed ID: 28438183
[TBL] [Abstract][Full Text] [Related]
14. The neural guidance receptor Plexin C1 delays melanoma progression.
Chen Y; Soong J; Mohanty S; Xu L; Scott G
Oncogene; 2013 Oct; 32(41):4941-9. PubMed ID: 23160370
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
Liu JD; Chen SH; Lin CL; Tsai SH; Liang YC
J Cell Biochem; 2001; 83(4):631-42. PubMed ID: 11746506
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin-5A downregulation is associated with enhanced migration and invasion of BRAF-positive melanoma cells under vemurafenib treatment in melanomas with heterogeneous BRAF status.
Komina AV; Palkina NV; Aksenenko MB; Lavrentev SN; Moshev AV; Savchenko AA; Averchuk AS; Rybnikov YA; Ruksha TG
Melanoma Res; 2019 Oct; 29(5):544-548. PubMed ID: 31116162
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.
Ruffini F; Tentori L; Dorio AS; Arcelli D; D'Amati G; D'Atri S; Graziani G; Lacal PM
Oncol Rep; 2013 Dec; 30(6):2887-96. PubMed ID: 24126726
[TBL] [Abstract][Full Text] [Related]
19. Plexin-B2 promotes invasive growth of malignant glioma.
Le AP; Huang Y; Pingle SC; Kesari S; Wang H; Yong RL; Zou H; Friedel RH
Oncotarget; 2015 Mar; 6(9):7293-304. PubMed ID: 25762646
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.
Eustace AJ; Crown J; Clynes M; O'Donovan N
J Transl Med; 2008 Sep; 6():53. PubMed ID: 18823558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
